Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000541919 | SCV000656949 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2025-01-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln422Alafs*10) in the MCCC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC1 are known to be pathogenic (PMID: 11181649, 15359379, 22642865). This variant is present in population databases (rs762463137, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with 3-Methylcrotonyl-CoA carboxylase deficiency (PMID: 11181649, 16010683). ClinVar contains an entry for this variant (Variation ID: 476392). For these reasons, this variant has been classified as Pathogenic. |
Eurofins Ntd Llc |
RCV000730035 | SCV000857743 | pathogenic | not provided | 2017-11-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000541919 | SCV002797247 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2024-03-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000541919 | SCV004191942 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000541919 | SCV002079101 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2020-12-11 | no assertion criteria provided | clinical testing |